Loading...
Loading...
Of the 9 tracked institutions holding CBIO, 3 have a 3-year clone track record — 3 of them beat the S&P. Average holder's clone alpha: +6.0pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 9 tracked institutional investors we monitor, CBIO (CRESCENT BIOPHARMA INC.) is held with a combined value of $127.87M across 7,304,909 shares. The largest holder is FMR LLC with a position worth $74.40M. 2 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$127.87M
Total Shares Held
7,304,909
Institutional Holders
9
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $74.40M | 0.00% | - |
| 2 | BlackRock, Inc. | $22.89M | 0.00% | +999.0% |
| 3 | MILLENNIUM MANAGEMENT LLC | $7.27M | 0.00% | +24.8% |
| 4 | VANGUARD GROUP INC | $6.61M | 0.00% | -15.3% |
| 5 | STATE STREET CORP | $5.68M | 0.00% | +707.8% |
| 6 | Point72 Asset Management, L.P. | $5.40M | 0.01% | - |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | $4.96M | 0.00% | -9.2% |
| 8 | TWO SIGMA ADVISERS, LP | $385.45K | 0.00% | New |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | $262.80K | 0.00% | New |
SEC Schedule 13D (activist) and 13G (passive) filings for CBIO. Filed when an investor acquires 5%+ ownership.
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of CBIO with a position worth $74.40M, representing 0.00% of their portfolio. In total, 9 institutional investors hold CBIO with a combined value of $127.87M.
In the most recent quarter, 2 funds opened a new position in CBIO. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $127.87M worth of CBIO stock across 9 positions. The largest institutional holder is FMR LLC with $74.40M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CBIO positions.
Last Close
$17.15
2026-08-21
YTD
+54.8%
46% of 52-week range